Drug Type AAV based gene therapy |
Synonyms RHO gene therapy (Beijing Chinagene Technology) |
Target |
Mechanism RHO gene transference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Beijing Chigenovo Co., Ltd.Startup |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Retinitis Pigmentosa | IND Approval | CN | 07 Feb 2024 |